Advanced Diagnostic Tools Transform Dry Eye Syndrome Detection and Management | Major Companies are AbbVi, Viatris Inc, Sun Pharmaceutical Industries, Inc.

The global dry eye syndrome market reached US$ 6.12 billion in 2023 and is expected to reach US$ 11.35 billion by 2031, growing at a CAGR of 8.1% during the forecast period 2024-2031

Dry Eye Syndrome Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/dry-eye-syndrome-market?nrk

Dry eye syndrome is a common eye condition that occurs when the eyes do not produce enough tears or when tears evaporate too quickly. It leads to symptoms such as irritation, redness, blurred vision, and discomfort. Causes include aging, prolonged screen time, environmental factors, and certain medical conditions. Treatments include artificial tears, prescription medications, and advanced therapies like intense pulsed light (IPL) treatment. The market for dry eye treatments is growing due to increased awareness and technological advancements in ophthalmic care.

Market Dynamics:

The market for dry eye syndrome is expected to experience significant growth during the forecast period, driven by increasing product development activities and regulatory approvals. In January 2023, Bausch + Lomb Corporation launched Blink NutriTears, an over-the-counter supplement clinically proven to support dry eye treatment in the U.S. market. Additionally, in September 2023, the company announced the U.S. commercial launch of Miebo, a perfluorohexyloctane ophthalmic solution designed to treat dry eye disease by directly addressing tear evaporation. Further expanding the treatment landscape, in October 2024, Novaliq received European Commission approval for Vevizye (Cyclosporine 0.1% eye drops solution) for dry eye treatment. Despite advancements, complications such as conjunctivitis, corneal ulceration, and scarring remain concerns for individuals with dry eye. Conjunctivitis, an inflammation of the conjunctiva, can lead to severe vision issues if untreated, while corneal ulceration and scarring may cause pain and permanent vision changes. Since symptoms of these complications often mimic those of dry eye, individuals should seek prompt medical attention if symptoms worsen.

Industry Development:

In October 2024, Aldeyra Therapeutics, Inc., a biopharmaceutical company dedicated to developing innovative treatments for immune and metabolic disorders, announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). The application is for reproxalap, an investigational topical ocular therapy, intended for the treatment of dry eye syndrome.

Key Players:

AbbVi, Viatris Inc, Sun Pharmaceutical Industries, Inc, Bausch + Lomb, Alcon Inc, Santen Pharmaceutical Co., Ltd, OASIS Medical, Inc, Prestige Consumer Healthcare Inc, OCuSOFT, Otsuka Pharmaceutical Co.

Growth Forecast Projected:

The Global Dry Eye Syndrome Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Dry Eye Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=dry-eye-syndrome-market

Market Segmentation:

By Type: Aqueous Deficient Dry Eye, Evaporative Dry Eye, Mixed.

By Treatment Type: Artificial Tears, Anti-Inflammatory Drugs, Nutritional Supplements, Others.

By Dosage Form: Gels, Eye Solutions, Ointments, Nasal Spray, Oral Formulations.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/dry-eye-syndrome-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Dry Eye Syndrome market?

➠ Who are the leading manufacturers in the global Dry Eye Syndrome industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Dry Eye Syndrome industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Dry Eye Syndrome market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.